1.

MATTERS OF ADMINISTRATION

1.1

Welcome and apologies

1.2

Minutes and recommendations of the 172nd MARC meeting

1.3

Declarations of potential conflicts of interest

2.

MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE

2.1

CARM quarterly report

3.

PHARMACOVIGILANCE REPORTS

3.1

Matters referred to the MARC under section 36 of the Medicines Act 1981

3.2

Matters referred to the MARC by Medsafe

3.2.1

Levonorgestrel emergency contraception and weight-based efficacy

3.2.2

Codeine – Safety concerns when used in children

3.2.3

Medroxyprogesterone and withdrawal syndrome

3.2.4

NSAIDs and cardiovascular risk

3.2.5

Risk Management Plan for nusinersen

3.2.6

Ulipristal acetate and drug induced liver injury

4.

MEDSAFE PHARMACOVIGILANCE ACTIVITIES

4.1

Report on standing agenda items

4.2

Medsafe pharmacovigilance activities

4.3

Prescriber Update

4.4

Quarterly summary of recent safety communications

5.

OTHER BUSINESS

5.1

Therapeutic products regulation project – Update